Flagship products
Hydrolysable Aim-Tconv
Ready-to-use, xeno-free ancillary for rapid conventional T-cell expansion ex vivo (research and clinical grades)
|
Magnetic Aim-Tconv
Ready-to-use, xeno-free ancillary for rapid conventional T-cell enrichment and activation ex vivo (research and clinical grades)
|
AimGel-Z
Ready-to-use platform for user’s choice of recombinant protein signals as research tools for cell therapeutics R&D.
|
Product strengths
Our R&D pipelines
Current market trends and needs
|
Allegrow Biotech has an initial focus on targeting the reagent market, with research institutes and biotechnology companies as the main users. Allegrow is created to assist and accelerate their innovations and clinical translations of cell therapeutics.
In the long run, Allegrow will expand to clinical applications, hitting bigger market and needs and benefiting more patients. |
|
Allegrow Biotech. |
|
Disclaimer Impressum Credits Cookie Policy Privacy Statement
© 2022 Allegrow Biotech Ltd. All Rights Reserved.